(5) Price segmentation between developed country markets and the poorest developing country markets is necessary to ensure that the poorest developing countries are supplied with essential pharmaceutical products at heavily reduced prices.
(5) Arenenud riikide turgude ja vaeseimate arengumaade turgude hinnad on tarvis teineteisest eraldada, et tagada vaeseimate arengumaade turgudele hädavajalike farmaatsiatoodete tarnimine oluliselt vähendatud hindadega.